Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder

Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections

(2020) Laura R Marks et al.   CLINICAL INFECTIOUS DISEASES

Integrating Responses to the Opioid Use Disorder and Infectious Disease Epidemics

(2020) Sandra A. Springer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Addressing the Intersection of Infectious Disease Epidemics and Opioid and Substance Use Epidemics

(2020) Sandra A. Springer et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Development of a Cascade of Care for responding to the opioid epidemic

(2019) Arthur Robin Williams et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Oral versus Intravenous Antibiotics for Bone and Joint Infection

(2019) Ho-Kwong Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Barbara R Haight et al.   LANCET

Opioids and Infectious Diseases: A Converging Public Health Crisis

(2019) Tara A Schwetz et al.   JOURNAL OF INFECTIOUS DISEASES

Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases

(2019) David P Serota et al.   CLINICAL INFECTIOUS DISEASES

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor – Active Surveillance in Selected Sites, United States, 2014–17

(2019) Alexia Y Zhang et al.   CLINICAL INFECTIOUS DISEASES

Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases

(2019) Nikhil Seval et al.   Open Forum Infectious Diseases

Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda

(2019) Sandra A Springer et al.   JOURNAL OF INFECTIOUS DISEASES

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014

(2018) Jon E. Zibbell et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community

(2018) Sandra A. Springer et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

(2018) Joshua D Lee et al.   LANCET

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

(2018) Michelle R. Lofwall et al.   JAMA Internal Medicine

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

(2018) Kasper Iversen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trends in Drug Use–Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017

(2018) Asher J. Schranz et al.   ANNALS OF INTERNAL MEDICINE

Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone

(2017) Yih-Ing Hser et al.   Journal of Addiction Medicine

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial

(2016) Yih-Ing Hser et al.   ADDICTION

Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002–12

(2016) Matthew V. Ronan et al.   HEALTH AFFAIRS

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

(2016) Joshua D. Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015

(2016) Philip J. Peters et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study

(2015) Roger D. Weiss et al.   DRUG AND ALCOHOL DEPENDENCE

Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence

(2015) Gail D’Onofrio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community

(2014) Angela Di Paola et al.   Contemporary Clinical Trials

Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients

(2014) Jane M. Liebschutz et al.   JAMA Internal Medicine

Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users

(2014) Judith I. Tsui et al.   JAMA Internal Medicine

Effectiveness of Long-Acting Reversible Contraception

(2012) Brooke Winner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners

(2012) Sandra A. Springer et al.   PLoS One

Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence

(2011) Roger D. Weiss   ARCHIVES OF GENERAL PSYCHIATRY

Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine

(2011) Daniel P. Alford et al.   ARCHIVES OF INTERNAL MEDICINE

Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative

(2011) Linda Weiss et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

(2011) Evgeny Krupitsky et al.   LANCET

Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials

(2011) Claudia Leucht et al.   SCHIZOPHRENIA RESEARCH

Long-Acting Injectable Versus Oral Naltrexone Maintenance Therapy With Psychosocial Intervention for Heroin Dependence

(2010) Adam C. Brooks et al.   JOURNAL OF CLINICAL PSYCHIATRY

Improving Clinical Outcomes in Treating Heroin Dependence

(2009) Gary K. Hulse et al.   ARCHIVES OF GENERAL PSYCHIATRY

Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study

(2009) Edle Ravndal et al.   DRUG AND ALCOHOL DEPENDENCE

Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference

(2009) Erin E. Krebs et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data

(2009) Carl van Walraven et al.   MEDICAL CARE

Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers

(2008) Alexander Y. Walley et al.   JOURNAL OF GENERAL INTERNAL MEDICINE